The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Diagnostic Drill-Down: New Research Suggests Genetic Autoinflammatory Roots

Diagnostic Drill-Down: New Research Suggests Genetic Autoinflammatory Roots

January 25, 2021 • By Mary Beth Nierengarten

  • Tweet
  • Email
Print-Friendly Version / Save PDF

ACR Convergence 2020—In the session titled Autoinflammatory Diseases: Mechanisms and Management, experts discussed the underlying immunopathology of autoinflammatory disease in adults.

You Might Also Like
  • Fellows’ Forum Case Report: Autoinflammatory Diseases and Roles of Genetic, Molecular Testing
  • Decoding Autoinflammatory Syndromes
  • The Latest Autoinflammatory Discoveries & Tips
Explore This Issue
February 2021
Also By This Author
  • A New Administration Brings Updated ACR Policy Positions

Polly Ferguson, MD, a pediatric rheumatologist and director of the division of pediatric rheumatology at University of Iowa Stead Family Children’s Hospital in Iowa City, opened the session talking about SAPHO (i.e., synovitis, acne, pustulosis, hyperostosis and osteitis), a rare syndrome in adults characterized by skin and osteoarticular manifestations and one with many aliases, including CRMO (i.e., chronic recurrent multifocal osteomyelitis), a syndrome used in pediatric rheumatology and characterized by sterile osteomyelitis in one or more locations with or without skin, intestine or joint inflammation.

Dr. Ferguson

Both syndromes share similar clinical manifestations, including osteo-articular symptoms (e.g., pain, stiffness, joint swelling/warmth) and dermatologic symptoms (i.e., palmar-plantar pustulosis (PPP), psoriasis vulgaris and severe acne).

Although no validated diagnostic criteria currently exist for SAPHO, Dr. Ferguson pointed to criteria proposed by Kahn in 2003 in which osteitis/osteomyelitis is fundamental to the diagnosis.1 Specific inclusion criteria proposed by Kahn include bone-joint involvement with palmoplantar pustulosis, bone-joint involvement with severe acne, isolated sterile hyperostosis/osteitis and CRMO in children. Exclusion criteria include bone tumors and non-inflammatory condensing bone lesions, such as osteopoikilosis and steopathia striata.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Data from two studies describing the clinical features of SAPHO patients highlight the need for improved diagnosis, Dr. Ferguson said. A 1999 study of 120 patients by Haymen found 91% had osteitis and 84% had skin disease, with a median age of onset of 37.7 years and a delay in diagnosis of nearly 20 years after first clinical manifestations of disease.2 A more recent 2020 study of 249 patients with SAPHO with PPP or severe acne found a median age of disease onset of 20 years for those with severe acne and 37 years for those with PPP, with a seven-year delay in diagnosis for those with severe acne and a one-year delay for those with PPP.3

No validated diagnostic criteria currently exist for SAPHO.

Dr. Ferguson discussed the immunopathology of SAPHO in which immune dysregulation results in pro-inflammatory cytokine production, with genetic models supporting the role of interferon-1 (IL-1) in its pathogenesis.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Currently, SAPHO is treated empirically with off-label agents due to the lack of FDA-approved medications. Nonsteroidal anti-inflammatory drugs (NSAIDs) are used most often but are inadequate, she said, along with non-biologic disease-modifying anti-rheumatic drugs, including methotrexate, sulfasalazine and (more recently) Janus kinase inhibitors.

Pages: 1 2 | Single Page

Filed Under: ACR Convergence, Conditions, Meeting Reports Tagged With: ACR Convergence 2020, autoinflammatory disease, SAPHO, SAPHO Syndrome, systemic autoinflammatory diseasesIssue: February 2021

You Might Also Like:
  • Fellows’ Forum Case Report: Autoinflammatory Diseases and Roles of Genetic, Molecular Testing
  • Decoding Autoinflammatory Syndromes
  • The Latest Autoinflammatory Discoveries & Tips
  • The Genetic Factor: Research Examines Genetic Heritability for Pediatric Autoimmune Diseases

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)